IS7219A - Lyfjablanda sem inniheldur (R) -bíkalútamíð - Google Patents

Lyfjablanda sem inniheldur (R) -bíkalútamíð

Info

Publication number: IS7219A
Authority: IS; Iceland
Prior art keywords: bicalutamide; pharmaceutical composition; composition containing; pharmaceutical; composition
Prior art date: 2001-10-15

Application number

IS7219A

Other languages

English (en)

Inventor

Kay Cahill Julie

Frances Bateman Nicola

Original Assignee

Astrazeneca Uk Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-15

Filing date

2004-04-14

Publication date

2004-04-14

2004-04-14 Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited

2004-04-14 Publication of IS7219A publication Critical patent/IS7219A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IS7219A 2001-10-15 2004-04-14 Lyfjablanda sem inniheldur (R) -bíkalútamíð IS7219A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0103424A SE0103424D0 (sv)	2001-10-15	2001-10-15	Pharmaceutical formulation
PCT/GB2002/004621 WO2003032950A1 (en)	2001-10-15	2002-10-11	Pharmaceutical formulation comprising (r) -bicalutamide

Publications (1)

Publication Number	Publication Date
IS7219A true IS7219A (is)	2004-04-14

Family

ID=20285650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7219A IS7219A (is)	2001-10-15	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð

Country Status (19)

Country	Link
US (1)	US20060058381A1 (is)
EP (1)	EP1439823A1 (is)
JP (1)	JP3639587B2 (is)
KR (1)	KR20050035163A (is)
CN (1)	CN1571658A (is)
AR (1)	AR036877A1 (is)
BR (1)	BR0213248A (is)
CA (1)	CA2462219A1 (is)
CO (1)	CO5580755A2 (is)
HU (1)	HUP0401369A3 (is)
IL (1)	IL161306A0 (is)
IS (1)	IS7219A (is)
MX (1)	MXPA04003520A (is)
NO (1)	NO20041485L (is)
PL (1)	PL368226A1 (is)
RU (1)	RU2004115023A (is)
SE (1)	SE0103424D0 (is)
WO (1)	WO2003032950A1 (is)
ZA (1)	ZA200402729B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2439366A1 (en) *	2001-02-27	2002-09-06	Julie Cahill	Pharmaceutical formulation comprising bicalutamide
WO2005067976A2 (en)	2004-01-20	2005-07-28	Novartis Ag	Direct compression formulation and process
JP2008531531A (ja) *	2005-02-23	2008-08-14	アストラゼネカアクチボラグ	方法
US20080045600A1 (en) *	2006-08-17	2008-02-21	Gawande Rahul S	Bicalutamide compositions
US20100048524A1 (en)	2008-03-14	2010-02-25	Angela Brodie	Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
US20110312916A1 (en)	2009-02-05	2011-12-22	Tokai Pharmaceuticals, Inc.	Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
CN101987086B (zh) *	2009-08-03	2012-07-18	北京化工大学	一种超细比卡鲁胺口服片剂及其制备方法
BR112014001440A2 (pt) *	2011-07-18	2017-02-21	Tokai Pharmaceuticals Inc	novas composições e métodos para o tratamento de câncer de próstata
EA033374B9 (ru)	2012-09-11	2019-12-18	Медивейшн Простейт Терапьютикс Ллк	Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения
CA2904170A1 (en)	2013-03-14	2014-09-25	University Of Maryland, Baltimore	Androgen receptor down-regulating agents and uses thereof
SG11201600525XA (en)	2013-08-12	2016-02-26	Tokai Pharmaceuticals Inc	Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
EA201791251A1 (ru)	2014-12-05	2017-11-30	Арагон Фармасьютикалз, Инк.	Противораковые композиции
MA41107A (fr) *	2014-12-05	2017-10-10	Aragon Pharmaceuticals Inc	Compositions anti-cancéreuses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3629237A (en) *	1968-09-12	1971-12-21	Shinetsu Chemical Co	Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
US4309405A (en) *	1979-08-09	1982-01-05	American Home Products Corporation	Sustained release pharmaceutical compositions
DE3372965D1 (en) *	1982-07-23	1987-09-17	Ici Plc	Amide derivatives
US4946686A (en) *	1987-09-24	1990-08-07	Merck & Co., Inc.	Solubility modulated drug delivery system
WO1992018106A1 (en) *	1991-04-16	1992-10-29	Nippon Shinyaku Co., Ltd.	Method of manufacturing solid dispersion
CA2181358A1 (en) *	1994-01-21	1995-07-27	Nancy M. Gray	Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
CA2439366A1 (en) *	2001-02-27	2002-09-06	Julie Cahill	Pharmaceutical formulation comprising bicalutamide
CA2443040A1 (en) *	2001-04-02	2002-10-17	Nicola Frances Bateman	Solid pharmaceutical composition comprising 4 -cyano-trifluoro-3-(4-fluorophenyl-sulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp

2001
- 2001-10-15 SE SE0103424A patent/SE0103424D0/xx unknown
2002
- 2002-10-11 IL IL16130602A patent/IL161306A0/xx unknown
- 2002-10-11 CA CA002462219A patent/CA2462219A1/en not_active Abandoned
- 2002-10-11 CN CNA028203747A patent/CN1571658A/zh active Pending
- 2002-10-11 JP JP2003535754A patent/JP3639587B2/ja not_active Expired - Fee Related
- 2002-10-11 KR KR1020047005493A patent/KR20050035163A/ko not_active Application Discontinuation
- 2002-10-11 BR BR0213248-6A patent/BR0213248A/pt not_active Application Discontinuation
- 2002-10-11 MX MXPA04003520A patent/MXPA04003520A/es unknown
- 2002-10-11 RU RU2004115023/15A patent/RU2004115023A/ru not_active Application Discontinuation
- 2002-10-11 HU HU0401369A patent/HUP0401369A3/hu unknown
- 2002-10-11 WO PCT/GB2002/004621 patent/WO2003032950A1/en active Application Filing
- 2002-10-11 AR ARP020103826A patent/AR036877A1/es unknown
- 2002-10-11 PL PL02368226A patent/PL368226A1/xx not_active Application Discontinuation
- 2002-10-11 EP EP02770069A patent/EP1439823A1/en not_active Withdrawn
- 2002-10-11 US US10/492,629 patent/US20060058381A1/en not_active Abandoned
2004
- 2004-04-07 ZA ZA200402729A patent/ZA200402729B/xx unknown
- 2004-04-13 NO NO20041485A patent/NO20041485L/no not_active Application Discontinuation
- 2004-04-14 IS IS7219A patent/IS7219A/is unknown
- 2004-05-12 CO CO04043957A patent/CO5580755A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200402729B (en)	2005-01-13
JP2004521963A (ja)	2004-07-22
AR036877A1 (es)	2004-10-13
RU2004115023A (ru)	2005-04-10
WO2003032950A1 (en)	2003-04-24
HUP0401369A3 (en)	2006-05-29
NO20041485L (no)	2004-04-13
HUP0401369A2 (hu)	2004-11-29
EP1439823A1 (en)	2004-07-28
CO5580755A2 (es)	2005-11-30
PL368226A1 (en)	2005-03-21
BR0213248A (pt)	2004-09-28
CA2462219A1 (en)	2003-04-24
CN1571658A (zh)	2005-01-26
US20060058381A1 (en)	2006-03-16
KR20050035163A (ko)	2005-04-15
MXPA04003520A (es)	2004-07-23
JP3639587B2 (ja)	2005-04-20
SE0103424D0 (sv)	2001-10-15
IL161306A0 (en)	2004-09-27

Publication	Publication Date	Title
EP1450824A4 (en)	2005-09-28	PHARMACEUTICAL COMPOSITION
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
IS2893B (is)	2014-09-15	Lyfjasamsetning sem inniheldur lantanefnasambönd
HK1072200A1 (en)	2005-08-19	Pro-micelle pharmaceutical compositions
GB0111597D0 (en)	2001-07-04	Pharmaceutical compositions
AU2003276549A8 (en)	2004-06-15	Pharmaceutical compositions containing a biguanide-glitazone combination
HUP0303163A3 (en)	2008-03-28	Tramadol-based pharmaceutical composition
GB0117057D0 (en)	2001-09-05	Pharmaceutical composition
EP1408896A4 (en)	2010-02-24	PHARMACEUTICAL COMPOSITION
GB0101227D0 (en)	2001-02-28	Pharmaceutical compounds
GB0101225D0 (en)	2001-02-28	Pharmaceutical compounds
IS7219A (is)	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð
GB0129117D0 (en)	2002-01-23	Pharmaceutical composition
GB0116107D0 (en)	2001-08-22	Pharmaceutical composition
GB0127805D0 (en)	2002-01-09	Pharmaceutical composition
GB0104752D0 (en)	2001-04-18	Pharmaceutical compositions
PL370037A1 (en)	2005-05-16	Pharmaceutical composition
IS6857A (is)	2003-06-23	Lyfjafræðileg samsetning sem innheldur sítalópram
GB2382302B (en)	2006-08-02	Pharmaceutical compositions
EE200300378A (et)	2003-10-15	Farmatseutiline kompositsioon
AU2002342940A8 (en)	2003-06-10	New pharmaceutical compounds
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS
HU0103049D0 (en)	2001-10-28	Pharmaceutical composition
GB0125061D0 (en)	2001-12-12	Pharmaceutical composition
GB0126732D0 (en)	2002-01-02	Pharmaceutical compositions